AIIC
AJU IB Investment Company Portfolio holdings
AUM
$91.9M
This Quarter Return
-8.97%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$71.8M
AUM Growth
+$71.8M
(-54%)
Cap. Flow
-$76.5M
Cap. Flow
% of AUM
-106.61%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
13
New
2
Increased
–
Reduced
1
Closed
7
Top Buys
| 1 |
Xilio Therapeutics
XLO
|
$10.7M |
| 2 |
Rallybio
RLYB
|
$7.2M |
Top Sells
| 1 |
Atea Pharmaceuticals
AVIR
|
$57.4M |
| 2 |
Apellis Pharmaceuticals
APLS
|
$20.6M |
| 3 |
Kymera Therapeutics
KYMR
|
$11.6M |
| 4 |
Clearside Biomedical
CLSD
|
$1.76M |
| 5 |
MTEM
Molecular Templates, Inc.
MTEM
|
$1.37M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Kymera Therapeutics
KYMR
$2.95B
| $29M | 40.43% | 457,059 -182,000 | -28% | -$11.6M |
|
2
Seer Inc
SEER
$115M
| $18.6M | 25.94% | 816,375 | – | – |
|
|
3
Xilio Therapeutics
XLO
$36.3M
| $10.7M | 14.88% | +667,742 | New | +$10.7M |
|
|
4
Rallybio
RLYB
$22.4M
| $7.2M | 10.03% | +754,678 | New | +$7.2M |
|
5
RAPT Therapeutics
RAPT
$188M
| $3.66M | 5.09% | 99,503 | – | – |
|
6
Sutro Biopharma
STRO
$72.7M
| $2.6M | 3.63% | 175,000 | – | – |
|
|
7
Apellis Pharmaceuticals
APLS
$3.48B
| – | – | -624,962 | Closed | -$20.6M |
|
|
8
Atea Pharmaceuticals
AVIR
$267M
| – | – | -1,637,331 | Closed | -$57.4M |
|
|
9
Clearside Biomedical
CLSD
$28.9M
| – | – | -293,555 | Closed | -$1.76M |
|
10
Kezar Life Sciences
KZR
$28.9M
| – | – | -128,916 | Closed | -$1.11M |
|
|
RNTX
11
Rein Therapeutics, Inc. Common Stock
RNTX
$32M
| – | – | -517,558 | Closed | -$528K |
|
|
MTEM
12
DELISTED
Molecular Templates, Inc.
MTEM
| – | – | -204,809 | Closed | -$1.37M |
|
|
BLCM
13
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| – | – | -25,651 | Closed | -$75K |
|